Browsing by Author "Vieito Villar, Maria"
Now showing items 1-10 of 10
-
BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas
Vieito Villar, Maria; Sepúlveda, Juan Manuel; Galvao De Aquiar, Vladimir; Hernández-Guerrero, T.; Doger, B.; Saavedra Gadea, Omar; Carpio Segura, Cecilia Carmen; Braña Garcia, Irene; Moreno, Victor (Nature Portfolio, 2023-03-13) -
First-In-Human Phase I Study of a Next-Generation, Oral, TGFβ Receptor 1 Inhibitor, LY3200882, in Patients with Advanced Cancer
Yap, Timothy A.; Vieito Villar, Maria; Baldini, Capucine; Sepúlveda, Juan Manuel; Kondo, Shunsuke; Simonelli, Matteo (American Association for Cancer Research, 2021-12) -
First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors
Davis, Elizabeth J; Martín Liberal, Juan Jesús; Kristeleit, Rebecca S; Cho, Daniel; Blagden, Sarah P; Berthold, Dominik; Vieito Villar, Maria (BMJ, 2022-10) -
Global Gene Expression Characterization of Circulating Tumor Cells in Metastasic Castration-Resistant Prostate Cancer Patients
León-Mateos, Luis; Casas, Helena; Anido, Urbano; Rapado-González, Óscar; Vieito Villar, Maria; Abalo, Alicia (MDPI, 2020-07-01) -
LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy
Pascual García, Mónica; Bonfill Teixidor, Ester; Planas Rigol, Ester; Rubio-Perez, Carlota; Iurlaro, Raffaella; Arias Piñeiro, Alexandra; Cuartas Maza, Ma Isabel; Sala Hojman, Ada; Escudero Monreal, Laura; Martínez Ricarte, Francisco Ramón; Huber Ruano, Isabel; Nuciforo, Paolo Giovanni; Braña Garcia, Irene; Garralda Cabanas, Elena; Vieito Villar, Maria; Espejo Ruiz, Carmen; Sahuquillo Barris, Joan; Tabernero Caturla, Josep; Seoane Suarez, Joan (Nature Research, 2019-06-11) -
Olutasidenib (FT-2102) in patients with relapsed or refractory IDH1-mutant glioma: A multicenter, open-label, phase Ib/II trial
de la Fuente, Macarena; Colman, Howard; Rosenthal, Mark; Van Tine, Brian; Levacic, Danijela; Walbert, Tobias; Vieito Villar, Maria (Oxford University Press, 2023-01) -
Phase I prognostic online (PIPO): A web tool to improve patient selection for oncology early phase clinical trials
Matos Garcia, Ignacio; Hierro Carbó, Cinta; Martín Liberal, Juan Jesús; Berche, Roger; Pedrola Gómez, Anna; Braña Garcia, Irene; Azaro Pedrazzoli, Analía Beatriz; Vieito Villar, Maria; Saavedra Gadea, Omar; Gardeazabal, Itziar; Hernando Calvo, Alberto; Alonso-Casal, Guzman; Galvao De Aquiar, Vladimir; Ochoa de Olza Amat, Maria; Ros Montañá, Fco. Javier; Viaplana Donato, Cristina; Elez Fernandez, Mª Elena; Rodon Ahnert, Jordi; Macarulla Mercadé, Teresa; Oaknin Benzaquen, Ana Mazaltob; Carles Galceran, Joan; Felip Font, Enriqueta; Tabernero Caturla, Josep; Garralda Cabanas, Elena; Villacampa Javierre, Guillermo; Saura Manich, Cristina; Muñoz Couselo, Eva; Dienstmann, Rodrigo (Elsevier, 2021-09) -
Phase I study of CC-90010, a reversible, oral BET inhibitor in patients with advanced solid tumors and relapsed/refractory non-Hodgkin's lymphoma
Sepúlveda, Juan Manuel; Vieito Villar, Maria; Hernández-Guerrero, T.; Doger, B.; Saavedra Gadea, Omar; Braña Garcia, Irene; Moreno, Victor (Elsevier, 2020-06) -
Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumors
Borazanci, Erkut; Schram, A. M.; Garralda Cabanas, Elena; Braña Garcia, Irene; Vieito Villar, Maria; Spreafico, A.; Seoane Suarez, Joan; Tabernero Caturla, Josep (Elsevier, 2022-08) -
Trotabresib (CC-90010) in combination with adjuvant temozolomide or concomitant temozolomide plus radiotherapy in patients with newly diagnosed glioblastoma
Vieito Villar, Maria; Simonelli, Matteo; De Vos, Filip; Marjolein Geurts; Lorenzi, Elena; Moreno, Victor (Oxford University Press, 2022-01)